Related Experiment Video
Updated: Aug 16, 2026

Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test
Published on: April 27, 2016
Increased circulating endothelins are not of cardiopulmonary origin in heart failure patients
Y Z Wang1, J P Goetze, R Videbaek
1Medical Department B, Cardiac Catheterization Laboratory, the Heart Centre, and Department of Clinical Biochemistry, Copenhagen University Hospital, Rigshospitalet, Denmark. wang@rh.dk
Insights
In heart failure patients, elevated endothelin-1 and big-endothelin levels primarily stem from increased peripheral endothelial secretion, not the cardiopulmonary system.
Area of Science:
- Cardiovascular Medicine
- Endocrinology
- Pharmacology
Background:
- Plasma concentrations of endothelin-1 and big-endothelin are elevated in heart failure.
- The specific origin of this increased secretion within the cardiopulmonary system is not fully understood.
Purpose of the Study:
- To determine if the cardiopulmonary system contributes to circulating endothelin-1 and big-endothelin levels in heart failure patients.
- To investigate the regional secretion of endothelin in the cardiovascular system.
Main Methods:
- Blood samples were collected during right heart catheterization from various cardiovascular regions, including the coronary sinus.
- Samples were analyzed from 12 chronic heart failure patients and 12 age-matched controls.
Main Results:
- Peripheral endothelin-1 concentrations were nearly threefold higher in heart failure patients compared to controls (p<0.01).
- Endothelin-1 levels were approximately 25% lower in coronary sinus plasma than in inferior caval vein plasma in heart failure patients (p<0.05).
- No significant differences in big-endothelin concentrations were observed across cardiovascular regions.
Conclusions:
- Increased plasma endothelin-1 and big-endothelin in heart failure predominantly originate from peripheral endothelial secretion.
- The cardiopulmonary system does not appear to be the primary source of elevated endothelin in this condition.
Objective:
Plasma concentrations of endothelin-1 and big-endothelin are increased in heart failure patients. However, the precise contribution of endothelin secretion from the cardiopulmonary system remains unresolved. The aim of this study was to investigate whether the cardiopulmonary system contributes to the circulating endothelin-1 and big-endothelin concentrations in heart failure patients.
Material And Methods:
Blood samples were obtained at right heart catheterization from different cardiovascular regions including the coronary sinus in chronic heart failure patients (n=12) and from age-matched control subjects (n=12).
Results:
The peripheral plasma concentrations of endothelin-1 were almost 3-fold higher in heart failure patients compared with the control subjects (1.25 pmol/l, 0.30-8.20 pmol/l (median, range) versus 0.46 pmol/l, 0.10-0.88 pmol/l, p<0.01). However, the endothelin-1 concentration was approximately 25% lower in plasma samples from the coronary sinus than in plasma from the inferior caval vein (p<0.05) in the heart failure patients. There were no differences in big-endothelin concentrations between any of the cardiovascular regions.
Conclusions:
In heart failure patients, increased plasma concentrations of endothelin-1 and big-endothelin mainly reflect an increased secretion from the peripheral endothelium.
Related Concept Videos
Heart Failure II: Pathophysiology
Heart Failure I: Introduction
Pathophysiology of Heart Failure
Heart Failure III: Clinical Manifestations
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
